Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
11.21%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 5.93Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 137.27M | $ 15.39M | 11.21% |
| 3/31/2025 | $ 142.13M | $ 17.02M | 11.97% |
| 12/31/2024 | $ 145.24M | $ 18.43M | 12.69% |
| 9/30/2024 | $ 148.44M | $ 19.74M | 13.3% |
| 6/30/2024 | $ 145.67M | $ 20.64M | 14.17% |
| 3/31/2024 | $ 140.46M | $ 21.29M | 15.16% |
| 12/31/2023 | $ 146.03M | $ 21.71M | 14.87% |
| 9/30/2023 | $ 145.87M | $ 22.7M | 15.56% |
| 6/30/2023 | $ 146M | $ 24.42M | 16.73% |
| 3/31/2023 | $ 148.1M | $ 33.45M | 22.59% |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 23.76%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average SB Comp % has been 17.45%.
- The median SB Comp % for KARYOPHARM THERAPEUTICS INC during this period was 15.01%
- KARYOPHARM THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 27.69%.
- The lowest SB Comp % recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe 11.21%
KARYOPHARM THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for KARYOPHARM THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 21.64M ] / Revenues [ $ 91.08M ]
(=) SB Comp % [ 23.76% ] KPTI - Stock Based Compensation Margin, Last 5 years
11.21%
Minimum
Jun 30, 2025
27.69%
Maximum
Jun 30, 2021
17.45%
Average
15.01%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |